Evidence map›Paper›PMID 30248224›Full record

ArticleLiver international : official journal of the International Association for the Study of the Liver2019

Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding-A national multicentre study.

Nikolaus Pfisterer, Florian Riedl, Thomas Pachofszky, Michael Gschwantler, Kurt König, Benjamin Schuster, Mattias Mandorfer, Irina Gessl, Constanze Illiasch, Eva-Maria Fuchs and 7 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Liver international : official journal of the International Association for the Study of the Liver, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Best Practices in Esophageal, Gastroduodenal, and Colonic Stenting.GE Portuguese journal of gastroenterology · 2023
    Review
  8. Diagnosis and Management of Esophagogastric Varices.Diagnostics (Basel, Switzerland) · 2023
    Review
  9. SX-ELLA Danis-Stent for Refractory Acute Esophageal Variceal Bleeding.GE Portuguese journal of gastroenterology · 2023
    Article
  10. Article
  11. Variceal Bleeding: Beyond Banding.Digestive diseases and sciences · 2022
    Review
  12. Article
  13. Review
  14. Article
  15. Where does TIPS fit in the management of patients with cirrhosis?JHEP reports : innovation in hepatology · 2020
    Review
  16. Article
  17. Article
  18. Biomaterials in Gastroenterology: A Critical Overview.Medicina (Kaunas, Lithuania) · 2019
    Review
  19. Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding-A national multicentre study.Liver international : official journal of the International Association for the Study of the Liver · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Nikolaus PfistererDivsion of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-1336-7250
Florian RiedlVienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-5772-1886
Thomas PachofszkyDivision of Gastroenterology and Hepatology, Krankenanstalt Rudolfstiftung, Krankenanstaltenverbund Wien (KAV), Vienna, Austria.
Michael GschwantlerWilhelminenspital, Krankenanstaltenverbund Wien (KAV), Vienna, Austria.ORCID 0000-0002-2523-1708
Kurt KönigDivision of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Benjamin SchusterDivsion of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Mattias MandorferDivsion of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.ORCID 0000-0003-2330-0017
Irina GesslDivsion of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Constanze IlliaschDivision of Gastroenterology and Hepatology, Krankenanstalt Rudolfstiftung, Krankenanstaltenverbund Wien (KAV), Vienna, Austria.
Eva-Maria FuchsDivision of Gastroenterology and Hepatology, Krankenanstalt Rudolfstiftung, Krankenanstaltenverbund Wien (KAV), Vienna, Austria.
Lukas UngerVienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria.
Werner DolakDivsion of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Andreas MaieronDivision of Gastroenterology and Hepatology, Universitätsklinikum St. Pölten, St. Pölten, Austria.
Ludwig KramerDivision of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Christian MadlDivision of Gastroenterology and Hepatology, Krankenanstalt Rudolfstiftung, Krankenanstaltenverbund Wien (KAV), Vienna, Austria.
Michael TraunerDivsion of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Thomas ReibergerDivsion of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-4590-3583
Medical University of Vienna · ATKrankenanstalt Rudolfstiftung der Stadt Wien · ATSigmund Freud Privatuniversität Wien · ATUniversitätsklinikum St. Pölten · ATVienna General Hospital · ATWiener Krankenanstaltenverbund · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurrent guidelines favour the use of bleeding stents over balloon tamponade (BT) for refractory variceal bleeding (VB) from oesophageal varices. However, data on the efficacy and safety of self-expandable metal SX-ELLA Danis stents (SEMS) are limited.

methodsCirrhotic patients receiving SEMS for VB at four tertiary care centres were included in this retrospective multicentre study. Rates of failure-to-control bleeding (within 5 days) and bleeding-related mortality (6 weeks) were assessed.

resultsSEMS controlled VB in 79.4% (27/34) of patients. In the rest of patients, other rescue treatments including endoscopic band ligation (EBL, n = 3), SEMS renewed (n = 2) or Linton (n = 2) were applied; however, VB was only controlled in one patient. Early rebleeding within six weeks occurred in 17.6% (6/34) patients. Median SEMS dwell time was three (IQR:6) days. Overall n = 13/34 (38.2%) patients died with SEMS in situ. After SEMS removal, rebleeding and bleeding-related death occurred in n = 7 (35%) and n = 5 (14.7%) patients respectively. Only 32.4% (10/34) patients did not experience any rebleeding within six weeks after SEMS removal. Bleeding-related mortality was 47.1% (n = 16/34) and the median survival after SEMS placement was 2.1 months. Notably, no patient received an early transjugular intrahepatic portosystemic shunt (TIPS). The most common adverse events were stent dislocations (n = 13; 38.2%), while ulcers/necrosis of the oesophageal mucosa was seen in only four (11.8%) patients.

conclusionSEMS controlled refractory VB in most patients. However, bleeding-related mortality remained high. While SEMS dislocations were frequent, ulcers/necrosis of the oesophagus was rare. Further studies should investigate whether the wider use of early TIPS reduces bleeding-related mortality after SEMS placement.

Indexed as

AdultAgedAustriaEndoscopy, GastrointestinalEsophageal and Gastric VaricesFemaleGastrointestinal HemorrhageHumansLiver CirrhosisMaleMiddle AgedPortasystemic Shunt, Transjugular IntrahepaticRetrospective StudiesStentsTreatment Outcomecirrhosisportal hypertensionself-expandable metal stentvariceal bleeding

Identifiers

PMID30248224
PMCPMC6587452
OpenAlexW2893567920

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.